Pro Medicus stock

PME · ASX · AUD

Compare Pro Medicus
$195.06Change from previous close: −3.27%Absolute change: −$6.59

Close · November 18, 2026

Price history

−22.33% over the period

1 year: from $251.14 (November 18, 2025) to $195.06 (November 18, 2026), −22.33%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 18, 2026$195.06
October 30, 2026$196.20
September 30, 2026$163.92
August 31, 2026$179.39
July 31, 2026$162.21
June 30, 2026$203.43
May 29, 2026$132.26
April 30, 2026$134.40
March 31, 2026$116.90
February 27, 2026$130.00
January 30, 2026$184.12
December 31, 2025$220.87
November 28, 2025$266.54
November 18, 2025$251.14

At a glance

  • The company

    Provides medical imaging software and services including radiology information systems, enterprise imaging platforms, and mobile applications to healthcare facilities

  • Latest results

    Quarter to June 30, 2026 · EPS $0.90 (estimate $0.69)

TickerLandia's take on Pro Medicus

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$107.75
52-wk high$272.85

−28.51% from the 52-week high

Analysts · 15 analysts

Average target$203.21+4.18% vs. price

Buy 9 · Hold 5 · Sell 1 · Buy

TickerLandia Fingerprint: Pro Medicus

Compared with similar companies: very high profitability, very high price, and very high financial strength.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Pro Medicus is cheaper than in the past and pricier than similar companies

On the latest fiscal year's earnings (2026), Pro Medicus's P/E today is 76.9, below the median of its last 10 fiscal years (116.5; between 59.1 and 258.9 from 2017 to 2026). Pro Medicus's Forward P/E: 85.8, +194% against the median of a group of 5 similar companies (29.2).

P/E compared with its history

Compared with 5 similar companies

Pro Medicus's metrics compared with similar companies
MetricPro MedicusPosition in the groupBand
Forward P/E85.8Middle
Operating margin74.9%High
ROE75.0%High
Debt/equity0.00Low
Price/book46.7High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Pro Medicus. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$136.91M

Latest quarter · Q2 2026

Net income

$94.12M

Latest quarter · Q2 2026

Quarterly net margin

68.7%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$21.07B
P/E
79.4
EPS
$2.54
Volume
158.61K
Daily trading
€26.93M
Dividend yield
0.35%
Last ex-dividend on September 7, 2026

How Pro Medicus is changing

All results
  • Revenue grew 30.9% a year on average over the last 5 years

  • Operating margin rose from 67.3% to 74.9%

  • Free cash flow equal to 69% of net income

Returns

Pro Medicus returns with dividends

$1,000 invested in Pro Medicus 5 years ago, on November 18, 2021, would be worth $3,224 today with dividends reinvested: +222.35% in total, +26.38% per year. On price alone it would be $3,164 (+216.40%).

PeriodPro MedicusS&P/ASX 200$1,000 becomes
1 month+9.81%+0.42%$1,098
6 months+55.40%+4.44%$1,554
Year to date−11.69%+1.94%$883
1 year−21.96%+4.89%$780
3 years+123.81%+25.85%$2,238
5 years+222.35%+20.38%$3,224
10 years+4,142.28%+65.75%$42,423

Over the last 6 months it has done better than 87% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment

The chart in detail

Pro Medicus: technical analysis

Pro Medicus is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 41.0% below its all-time closing high ($330.48, July 17, 2025).

Trend
Upward
RSI (14 sessions)
52
Between 30 and 70
vs 200-session average
+21.82%

Support and resistance

Price areas where Pro Medicus has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$210.20+7.76%2 touches, last on August 21, 2026
  2. Last price$195.06
  3. Support$169.18−13.27%4 touches, last on September 18, 2026
  4. Support$153.79−21.16%3 touches, last on October 5, 2026
  5. Support$140.64−27.90%2 touches, last on May 5, 2026

Volatility and risk

Over the last year it has moved more than the S&P/ASX 200.

Beta (1 year) vs S&P/ASX 200
1.21
Volatility (60 sessions, annualised)
36.8%
Largest fall in the last year
−59.45%

In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Pro Medicus: seasonality

Average monthly price change over 26 years

+0.1%Jan−3.2%Feb−1.0%Mar+4.5%Apr+1.3%May−0.9%Jun+6.5%Jul+7.1%Aug−0.1%Sep+5.1%Oct+7.5%Nov+2.8%Dec

Over the last 26 years, the strongest month for Pro Medicus has been November: +7.50% on average, positive in 19 years out of 26. The weakest has been February: −3.17% on average, positive in 12 years out of 26.

Show chart data
MonthAverageMedianPositive years
January+0.05%−2.49%12 of 26
February−3.17%−2.19%12 of 26
March−1.02%−0.76%11 of 26
April+4.49%+3.25%15 of 26
May+1.25%−1.21%10 of 26
June−0.89%−0.88%12 of 26
July+6.52%+4.77%19 of 26
August+7.10%+7.54%19 of 26
September−0.10%−1.21%12 of 26
October+5.07%+0.18%13 of 26
November+7.50%+7.47%19 of 26
December+2.83%+0.33%13 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Pro Medicus and its competitors

Sales of medical imaging software reach customers in Australia, Europe and North America, where the company supplies software and services to hospitals and healthcare organisations. Its core offering is Visage RIS, a radiology information system covering patient registration, billing, scheduling, reporting and integration with picture archive and communication systems, alongside Visage 7, an imaging platform that lets radiologists, physicians and clinicians view 2-D, 3-D and 4-D images.

Headquarters
Richmond, Australia
Employees
153
Founded
1983
Chief executive
Sam Hupert
Pro Medicus and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Pro MedicusPME$14.19B74.9%79.4+55.40%
M32413$7.64B19.5%26.5+28.11%
XtalPi Holdings2228$3B-124.6%—−35.62%
4DMedical4DX$933.07M-813.7%—−47.12%
Tempus AITEM$11.81B-18.5%—+44.39%
DoximityDOCS$5.85B27.1%45.5+64.00%

Same industry or related industries, similar size. Compare Pro Medicus with its competitors · Full profile